Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% weight-loss over 42 weeks.
Speculation about what's next for Havana comes as the U.S. continues to attack Iran and shortly after Trump ordered U.S. forces to depose Venezuela's president.